Agios Pharmaceuticals(AGIO) - 2025 Q4 - Annual Results

Exhibit 99.1 Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update CAMBRIDGE, Mass., Feb. 12, 2026 – Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial- stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced financial results and updates for the fourth quarter and year ended December 31, 2025. "2025 was another year of continued execution across our portfolio, highlighted by the historic U.S. ...